Trusted Resources: Education
Scientific literature and patient education texts
Corneal Cloudiness: A Presenting Feature of Mucopolysaccharidosis Type I
source: Indian journal of pediatrics
year: 2021
authors: Khurana S,Gupta PC,Behera RK,Singh H,Ram J
summary/abstract:A 10-y-old ‘short-statured’ male presented to us with decreased vision in both the eyes since birth. Ocular examination revealed cloudy corneas in both the eyes (Fig. 1a, b). Family history was unremarkable. Suspecting it to be mucopolysaccharidosis, the child was referred to a pediatrician. Systemic examination revealed global developmental delay, short stature, abdominal distension, umbilical hernia, and hepatosplenomegaly with dysmorphic facial features like frontal bossing, saddle nose, wide mouth, and macroglossia. As the patient had frank corneal clouding, skeletal dysplasia, umbilical hernia, and intellectual impairment, he was most likely to have mucopolysaccharidosis type I, Hurler syndrome. The child was planned for sequential penetrating keratoplasty. For the disorder, the option of enzyme replacement therapy was discussed with the parents, but could not be materialized because of financial constraints.
organization: Department of Ophthalmology, Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.DOI: 10.1007/s12098-021-03855-w
read more
Related Content
-
Mucopolysaccharidoses (MPS) and Gene TherapyMucopolysaccharidoses (MPS) are a group ...
-
A 22 Year Old Rotherham Man, no Longer Walk Up His StairsA Yorkshire community has launched a fun...
-
The MPS I-H Diagnostic Journeyhttps://www.youtube.com/watch?v=jSq5tQD4...
-
Stem Cell Transplant for Bridgnorth Boy With Rare ConditionTwenty-two-month-old Gunner, from Bridgn...
-
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Market Research Report – Global Clinical Trials Review, H2, ...The "Mucopolysaccharidosis I (MPS I) (Hu...
-
UCSF – Lysosomal Storage Disease CenterThe UCSF Lysosomal Storage Disease Cente...
-
Experimental MPS 1 Therapy Shows Biomarker Activity, Improved FunctionREGENXBIO presented results from its ong...